Genitourinary Tumors and Radiation Therapy: Current Advances and Future Directions
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nuclear Medicine & Radiology".
Deadline for manuscript submissions: 20 October 2026 | Viewed by 924
Special Issue Editor
Special Issue Information
Dear Colleagues,
As we all know, radiation treatment has a vital role in the treatment of prostate, bladder, and kidney cancers. However, radiation treatment can also be associated with short- and long-term toxicity. Most recently, the development and usage of biomarkers have helped improve personalization for the treatment of genitourinary diseases. The aim of this Special Issue is to present original clinical research that has helped improve outcomes and quality of life for patients with bladder, kidney, and/or prostate cancer. Specifically, we are considering research topics focused on clinical outcomes, both prospective trials and retrospective reviews, as well as meta-analyses of large data and various relevant quality of life topics. Additionally, we welcome any papers focusing on novel treatment techniques, such as adaptive radiotherapy, in the setting of treatment for GU cancers.
I look forward to receiving your contributions.
Dr. Shalini Moningi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- prostate cancer
- bladder cancer
- kidney cancer
- radiation therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
